Located within a dedicated suite, the mixer features a ‘clean in place’ design to reduce the changeover times and consumption of water and energy associated with traditional machine clean-down routines. The new granulation suite is scheduled to become operational in the third quarter of 2024, Adare said.

“Our Pessano facility has long provided our customers with superior oral technologies, including micro and mini tablets, plain and coated tablets, and capsules,” commented Tom Sellig, CEO of Adare Pharma Solutions. “Pessano’s powerful new mixer granulator, along with the site’s expanded packaging and warehousing offerings, allows us to provide even broader capabilities and further meet the needs of our customers.”

The 20,400 m² facility provides R&D services for formulation and process development, with an integrated transition to manufacturing. It is capable of manufacturing a wide range of solid dosage forms at both clinical and commercial scales, including granules, capsules, and tablets. The site also provides controlled substance and organic solvent capabilities.